Vancomycin HCl in 0.9 % Sodium Chloride Injection, USP, 1,250 mg/250 mL, Single Use Bag for IV In...

FDA Recall #D-0425-2022 — Class II — December 6, 2021

Recall #D-0425-2022 Date: December 6, 2021 Classification: Class II Status: Terminated

Product Description

Vancomycin HCl in 0.9 % Sodium Chloride Injection, USP, 1,250 mg/250 mL, Single Use Bag for IV Injection (Preservative Free), 250 mL pre-filled bag, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1456-01

Reason for Recall

Lack of Assurance of Sterility

Recalling Firm

Edge Pharma, LLC — Colchester, VT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1795 bags

Distribution

nationwide

Code Information

09-2021-13@3 12/27/2021 & 09-2021-30@5 01/13/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated